A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combine With Toripalimab in Patients With Advanced HCC and Other Solid Tumors
Clinical trial NCT05149027 · UNKNOWN
Trial details
- NCT number
- NCT05149027
- Sponsor
- Harbour BioMed (Guangzhou) Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-20
- Primary completion
- 2024-05-30
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.